Anthrax - 40 Studies Found Completed : Trial of rPA-102 Vaccine in Healthy Adult Volunteers : Anthrax : 2005-01-05 : Biological: rPA102 Not yet recruiting : An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis : Infection, Bacterial Anthrax : 2017-03-17 : Other: Collection of samples T Completed : Ciprofloxacin BioThrax Co-Administration Study : Anthrax : 2012-12-14 : Biological: BioThrax route of Completed : Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults : Anthrax : 2011-12-12 : Biological: BioThrax BioThrax, 0.5 mL administered subcutaneously on days 0, 14, and 28. Completed : Placebo-Controlled, Sequential Group, Single Dose, Dose-Escalation Study to Evaluate the Safety and PK of ETI-204 : Anthrax : 2011-10-14 : Drug: ETI-204, "Anthim" Completed : Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects : Anthrax : 2010-12-17 : Drug: Normal Saline for Injection Completed : Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) : Anthrax : 2010-09-13 : Drug: AVP-21D9 intravenously, Terminated : Ph1 Study of Valortim and Doxycycline in Humans : Anthrax : 2009-08-24 : Drug: Doxycycline and Valortim Suspended : Ph1 Study of Valortim and Ciprofloxacin in Humans : Anthrax : 2009-08-22 : Drug: Ciprofloxacin and Valortim Completed : Open-Label, Randomized, Parallel Group Study to Assess the Safety, Tolerability and PK of ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers : Inhalational Anthrax : 2013-09-20 : Biological: ETI-204 Intravenou <<< Previous | Next >>>
